Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients

International Journal of Biological Markers

Volumn 15, Issue 4, 2000, Pages 300-307

  Salbe, C ^a   Trevisiol, C ^a   Ferruzzi, E ^a   Mancuso, T ^a   Nascimbeni, R ^a   DiFabio, F ^a   Salerni, B ^a   Dittadi, R ^a  

^a Ospedale Civile   (Italy)

Author keywords

Circulating DNA; Colorectal cancer; K RAS mutation; Mutant enriched PCR; Serum

Indexed keywords

DNA; RAS PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; ENZYMATIC ASSAY; FEMALE; HUMAN; MALE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; SERUM; TISSUE LEVEL;

EID: 0034524996     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080001500404     Document Type: Article

References (47)

1. Detection of H-ras mutations in urine sediments by a mutant-enriched PCR technique
2. Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA)
3. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
4. Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by Point-EXACCT
5. Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma
6. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary structure
7. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination
8. Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumours by mutant-allele-specific amplification (MASA)
9. Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients
10. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR
11. Soluble normal and mutated DNA sequences from single-copy genes in human blood
12. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
13. Neoplastic characteristics of the DNA found in the plasma of cancer patients
14. Microsatellite alterations in plasma DNA of small cell lung cancer patients
15. Microsatellite alterations in serum DNA of head and neck cancer patients
16. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
17. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
18. Detection of K-ras mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features
19. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
20. Detection of pancreatic carcinoma. Diagnostic value of K-ras mutations in circulating DNA from serum
21. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
22. Detection of tumour DNA in serum of colorectal cancer patients
23. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
24. Molecular detection of genetic alterations in the serum of colorectal cancer patients
25. Genetic alterations during colorectal-tumour development
26. A genetic model for colorectal tumorigenesis
27. Genetic alterations in the adenoma-carcinoma sequence
28. The multistep nature of cancer
29. Genetic pathways in colorectal and other cancers
30. Prevalence of ras gene mutations in human colorectal cancers
31. Ras oncogenes in human cancer: A review
32. Survival and acquired genetic alterations in colorectal cancer
33. K-ras mutation in colorectal cancer - Relations to patient age, sex andw tumour location
34. Kirsten ras mutations in patients with colorectal cancer: The multicenter "RASCAL" study
35. Avoiding false positives with PCR
36. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
37. Detection of circulating tumour cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease
38. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
39. Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogeneous leukaemia
40. K-ras point mutations in the blood plasma DNA of patients with colorectal tumour
41. Free DNA in the serum of cancer patients and the effect of therapy
42. Microsatellite instability in cancer of the proximal colon
43. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique
44. Rapid and sensitive non-radioactive detection of mutant K-ras genes via 'enriched' PCR amplification
45. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
46. Microsatellite instability in colorectal adenocarcinoma cell lines that have full length adenomatous polyposis coli protein
47. RAS protein farnesyltransferase: A strategic target for anticancer therapeutic development